Adler, E. D., Voors, A. A., Klein, L., Macheret, F., Braun, O. O., Urey, M. A., Zhu, W., Sama, I., Tadel, M., Campagnari, C., Greenberg, B., & Yagil, A. (2020). Improving risk prediction in heart failure using machine learning. European Journal of Heart Failure, 22(1), 139–147.

Article  PubMed  Google Scholar 

Australian Institute of Health and Welfare (2021a) Alcohol and other drug treatment services in Australia annual report, AIHW, Australian Government. Accessed 18 Feb 2023

Australian Institute of Health and Welfare (2021b) Alcohol, tobacco & other drugs in Australia, AIHW, Australian Government. Accessed 20 Feb 2023

Bates, S. (2010). Progress towards personalized medicine. Drug Discovery Today, 15(3–4), 115–120. https://doi.org/10.1016/j.drudis.2009.11.001

Article  PubMed  Google Scholar 

Calderwood, L., & Lessof, C. (2009). Enhancing longitudinal surveys by linking to administrative data. In P. Lynn (Ed.), Methodology of Longitudinal Surveys (pp. 55–71). John Wiley & Sons.

Chapter  Google Scholar 

Chang, H. Y., Krawczyk, N., Schneider, K. E., Ferris, L., Eisenberg, M., Richards, T. M., Lyons, B. C., Jackson, K., Weiner, J. P., & Saloner, B. (2019). A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients. Drug and Alcohol Dependence, 201, 127–133.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, T., Du, J., Zhong, N., Zhao, Y., Sun, H., Chen, Z., Jiang, H., & Zhao, M. (2020). Trajectories of heroin use predict relapse risk among heroin-dependent patients: A 5-year follow-up study. Journal of Clinical Neuroscience, 76, 134–139.

Article  PubMed  Google Scholar 

Chen, T., Zhong, N., Du, J., Li, Z., Zhao, Y., Sun, H., Chen, Z., Jiang, H., & Zhao, M. (2019). Polydrug use patterns and their impact on relapse among heroin-dependent patients in Shanghai China. Addiction, 114(2), 259–267.

Article  PubMed  Google Scholar 

Chrzanowska, A., Man, N., Sutherland, R., Degenhardt, L., & Peacock, A. (2021). Trends in Drug-Induced Deaths in Australia, 1997–2019. https://doi.org/10.26190/g2bk-t998

Damen, J. A. A. G., Hooft, L., Schuit, E., Debray, T. P. A., Collins, G. S., Tzoulaki, I., Lassale, C. M., Siontis, G. C. M., Chiocchia, V., Roberts, C., Schlüssel, M. M., Gerry, S., Black, J. A., Heus, P., Van Der Schouw, Y. T., Peelen, L. M., & Moons, K. G. M. (2016). Prediction models for cardiovascular disease risk in the general population: Systematic review. BMJ (Online), 353. https://doi.org/10.1136/bmj.i2416

Darke, S. (2011). The Life of the Heroin User: Typical Beginnings. Cambridge University Press.

Book  Google Scholar 

Darke, S., Hall, W., Wodak, A., Heather, N., & Ward, J. (1992). Development and validation of a multidimensional instrument for assessing outcome of treatment among opiate users: The opiate treatment index. Addiction, 87(5), 733–742.

CAS  Google Scholar 

Darke, S., Marel, C., Mills, K. L., Ross, J., Slade, T., Burns, L., & Teesson, M. (2014). Patterns and correlates of non-fatal heroin overdose at 11-year follow-up: Findings from the Australian Treatment Outcome Study. Drug and Alcohol Dependence, 144, 148–152. https://doi.org/10.1016/j.drugalcdep.2014.09.001

Article  PubMed  Google Scholar 

Darke, S., Marel, C., Mills, K. L., Ross, J., Slade, T., & Teesson, M. (2016). Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001–2015. Drug and Alcohol Dependence, 162, 206–210. https://doi.org/10.1016/j.drugalcdep.2016.03.010

Article  PubMed  Google Scholar 

Darke, S., Marel, C., Ross, J., Mills, K. L., Slade, T., & Tessson, M. (2015). Health service utilization among heroin users: 11-year follow-up of the Australian Treatment Outcome Study Cohort. Addictive Disorders and Their Treatment, 14(3), 159–166. https://doi.org/10.1097/ADT.0000000000000069

Article  Google Scholar 

Darke, S., Ross, J., Mills, K. L., Williamson, A., Havard, A., & Teesson, M. (2007). Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS). Addictive Behaviors, 32(9), 1897–1906. https://doi.org/10.1016/J.ADDBEH.2007.01.014

Article  PubMed  Google Scholar 

Darke, S., Ross, J., Teesson, M., Ali, R., Cooke, R., Ritter, A., & Lynskey, M. (2005). Factors associated with 12 months continuous heroin abstinence: Findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment, 28(3), 255–263. https://doi.org/10.1016/J.JSAT.2005.01.006

Article  PubMed  Google Scholar 

Darke, S., Topp, L., Kaye, S., & Hall, W. (2002). Heroin use in New South Wales, Australia, 1996–2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction, 97(2), 179–186. https://doi.org/10.1046/J.1360-0443.2002.00032.X

Article  PubMed  Google Scholar 

Darke, S., Williamson, A., Ross, J., & Teesson, M. (2006). Residential rehabilitation for the treatment of heroin dependence: Sustained heroin abstinence and drug-related problems 2 years after treatment entrance. Addictive Disorders and Their Treatment, 5(1), 9–18. https://doi.org/10.1097/01.ADT.0000210702.63165.81

Article  Google Scholar 

Davoli, M., Bargagli, A. M., Perucci, C. A., Schifano, P., Belleudi, V., Hickman, M., Salamina, G., Diecidue, R., Vigna-Taglianti, F., & Faggiano, F. (2007). Risk of fatal overdose during and after specialist drug treatment: The VEdeTTE study, a national multi-site prospective cohort study. Addiction, 102(12), 1954–1959. https://doi.org/10.1111/j.1360-0443.2007.02025.x

Article  PubMed  Google Scholar 

de Andrade, D., Elphinston, R. A., Quinn, C., Allan, J., & Hides, L. (2019). The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review. Drug and Alcohol Dependence, 201, 227–235.

Article  PubMed  Google Scholar 

Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., & Larney, S. (2019). Global patterns of opioid use and dependence: Harms to populations, interventions, and future action. The Lancet, 394(10208), 1560–1579. https://doi.org/10.1016/S0140-6736(19)32229-9

Article  CAS  Google Scholar 

Degenhardt, L., Whiteford, H. A., Ferrari, A. J., Baxter, A. J., Charlson, F. J., Hall, W. D., Freedman, G., Burstein, R., Johns, N., Engell, R. E., Flaxman, A., Murray, C. J. L., & Vos, T. (2013). Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. The Lancet, 382(9904), 1564–1574. https://doi.org/10.1016/S0140-6736(13)61530-5

Article  Google Scholar 

DeRubeis, R. J., Cohen, Z. D., Forand, N. R., Fournier, J. C., Gelfand, L. A., & Lorenzo-Luaces, L. (2014). The personalized advantage index: Translating research on prediction into individualized treatment recommendations A Demonstration. Plos ONE, 9(1), e83875. https://doi.org/10.1371/journal.pone.0083875

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Flynn, P. M., Joe, G. W., Broome, K. M., Simpson, D. D., & Brown, B. S. (2003). Recovery from opioid addiction in DATOS. Journal of Substance Abuse Treatment, 25(3), 177–186. https://doi.org/10.1016/S0740-5472(03)00125-9

Article  PubMed  Google Scholar 

Gardner, L. A., Stockings, E., Champion, K. E., Mather, M., & Newton, N. C. (2023). Alcohol initiation before age 15 predicts earlier hazardous drinking: A survival analysis of a 7-year prospective longitudinal cohort of Australian adolescents. Addiction. https://doi.org/10.1111/add.16376

Article  PubMed  Google Scholar 

Glanz, J. M., Narwaney, K. J., Mueller, S. R., Gardner, E. M., Calcaterra, S. L., Xu, S., Breslin, K., & Binswanger, I. A. (2018). Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy. Journal of General Internal Medicine, 33(10), 1–8. https://doi.org/10.1007/S11606-017-4288-3/TABLES/5

Article  Google Scholar 

Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (1999). Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence, 57(2), 89–98. https://doi.org/10.1016/S0376-8716(99)00086-1

Article  CAS  PubMed  Google Scholar 

Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (2000). Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug and Alcohol Dependence, 60(3), 275–286. https://doi.org/10.1016/S0376-8716(00)00109-5

Article  CAS  PubMed  Google Scholar 

Grol, R., & Grimshaw, J. (2003). From best evidence to best practice: Effective implementation of change in patients’ care. In Lancet (Vol. 362, Issue 9391, pp. 1225–1230). Elsevier. https://doi.org/10.1016/S0140-6736(03)14546-1

Gunes F, Wolfinger R, Tan P.-Y (2017) Stacked ensemble models for improved prediction accuracy. Presented at the SAS Global Forum Conference, Cary, NC: SAS Institute Inc

Heo KN, Lee JY, Ah YM (2022) Development and validation of a risk-score model for opioid overdose using a national claims database. Sci Rep. 12(1):4974. https://doi.org/10.1038/s41598-022-09095-y

Hser, Y. I. (2007). Predicting long-term stable recovery from heroin addiction: Findings from a 33-year follow-up study. Journal of Addictive Diseases, 26(1), 51–60. https://doi.org/10.1300/J069v26n01_07

Article  PubMed  Google Scholar 

Hser, Y.-I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015). Long-term course of opioid addiction. Harvard Review of Psychiatry, 23(2), 76–89.

Article  PubMed  Google Scholar 

Hser, Y. I., Grella, C. E., Hsieh, S. C., Anglin, M. D., & Brown, B. S. (1999). Prior treatment experience related to process and outcomes in DATOS. Drug and Alcohol Dependence, 57(2), 137–150. https://doi.org/10.1016/S0376-8716(99)00081-2

Article  CAS  PubMed  Google Scholar 

Hser, Y.-I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58(5), 503–508. https://doi.org/10.1001/ARCHPSYC.58.5.503

Article  CAS  PubMed  Google Scholar 

Hser, Y.-I., Huang, D., Saxon, A. J., Woody, G., Moskowitz, A. L., Matthews, A. G., & Ling, W. (2017). Distinctive trajectories of opioid use over an extended follow-up of patients in a multi-site trial on buprenorphine+naloxone and methadone. Journal of Addiction Medicine, 11(1), 63–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11(4), 261–278. https://doi.org/10.1037/0893-164X.11.4.261

Article  Google Scholar 

Hunt, C., & Andrews, G. (1995). Comorbidity in the anxiety disorders: The use of a life-chart approach. Journal of Psychiatric Research, 29(6), 467–480.

Article  CAS  PubMed  Google Scholar 

Jackson, C. T., Covell, N. H., Frisman, L. K., & Essock, S. M. (2005). Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. Journal of Dual Diagnosis, 1(1), 49–63. https://doi.org/10.1300/J374V01N01_05

Article  Google Scholar 

Jimenez-Treviño, L., Saiz, P. A., García-Portilla, M. P., Díaz-Mesa, E. M., Sánchez-Lasheras, F., Burón, P., Casares, M. J., Marina, P., Gutiérrez, E., & Bobes, J. (2011). A 25-year follow-up of patients admitted to methadone treatment for the first time: Mortality and gender differences. Addictive Behaviors, 36(12), 1184–1190. https://doi.org/10.1016/j.addbeh.2011.07.019